Press release
FLXIRE Therapeutics Joins LERO Consortium for the Development of ScorpION(C) Electrophysiology Analytics for Neuropsychiatric Diseases
Image: https://www.globalnewslines.com/uploads/2026/01/de3b06a2ea4c13e09455e29926ba7f64.jpg
FLXIRE Thera controls the development of the ScorpION(C) patch-clamp electrophysiology analytic software to bridge the technology gap in data production and analytics by deploying ML methods for dynamic signal processing.
The application of such data processing spans multiple subdisciplines of pre-clinical drug development; from early TargetID & Target validation; Tool, Lead, and Drug Candidates; early Safety & Toxicology assessment, & clinical safety profiling. FLXIRE is pursuing development of AI/ML predictive analytics relevant to neuropsychiatric disease therapeutics including Drug-resistant epilepsy, anxiety, depressive disorders, and schizophrenia. FLXIRE and LERO will develop patch-clamp analytic tools for FLXIRE's ScorpION(C) platform that allow researchers to deploy:
* CN-iPSC QC pipelines to monitor differentiation quality;
* Network-level simulations for ion channels (Digital Neuron simulation models);
* Digital twin phenotypic screening analytics, and;
* Neuronal PMPK and Safety & Toxicology predictive analytics.
Strategic Benefits to the Partners
* For FLXIRE Therapeutics: The collaboration provides access to the exceptional ecosystem of ML and Software development resources in Ireland, including ML in bioassay analytics, dynamic signal processing expertise developed from autonomous vehicles technologies, and the excellent economic ecosystem to nurturing startups.
* For LERO: FLXIRE joining the consortium expands its biotechnology expertise and interface with existing and proven regulatory frameworks and drug discovery paradigms. LERO will gain access to a variety of electrophysiology datasets, expand collaborative networks to include drug regulators and epilepsy research and psychiatric drug development organisations.
"We are very fortunate to partner with LERO. It is a major consideration in domiciling our operations in Limerick, where we found superb software and AI analytics research and development, and in convergence with late stage pre-clinical and clinically relevant drug development ecosystems," said Eli Black, Ph.D., CEO of Fluxion Therapeutics. "This collaboration allows us to develop software tools for TargetID and validation efforts in an exceptional environment."
About FLXIRE Therapeutics
FLXIRE Therapeutics is an Irish start-up in pre-clinical analytic and assay development. The company specializes in large-scale electrophysiology data handling and the integration of "Physiomics" Copyright -the nexus of ion channel analytics and systems biology.
About LERO, the Research Ireland Centre for Software
The University of Limerick-based software research centre, brings together expert software teams from universities and institutes of technology across Ireland in a co-ordinated centre of research excellence with a strong industry focus. Making "Irish Software" a synonym to "high-quality, well-researched" is LERO's mission. With global recognition, LERO is a pillar of Ireland's lead in the software sector.
Media Contact
Company Name: Fluxion Therapeutics Inc
Contact Person: Ron Demuth
Email: Send Email [http://www.universalpressrelease.com/?pr=flxire-therapeutics-joins-lero-consortium-for-the-development-of-scorpionc-electrophysiology-analytics-for-neuropsychiatric-diseases]
Phone: 858-717-2699
Country: United States
Website: https://www.fluxiontherapeutics.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FLXIRE Therapeutics Joins LERO Consortium for the Development of ScorpION(C) Electrophysiology Analytics for Neuropsychiatric Diseases here
News-ID: 4345344 • Views: …
More Releases from Getnews
Fluxion Therapeutics and University of Michigan's CCG Partner to Transform Ion C …
Ann Arbor, MI, USA - January 12, 2026 - Fluxion Therapeutics and the Center for Chemical Genomics (CCG) at the University of Michigan have entered a two-year research collaboration to develop artificial intelligence (AI) and machine learning (ML) models for the automated analysis of ion channel electrophysiology.
Image: https://www.globalnewslines.com/uploads/2026/01/de3b06a2ea4c13e09455e29926ba7f64.jpg
The partnership combines Fluxion's proprietary AI-driven analytics with the CCG's high-throughput screening (HTS) infrastructure. Together, the organizations will develop 'Omics-scale datasets to standardize…
Fluxion Therapeutics Appoints Vince Groppi, Ph.D., to Scientific Advisory Board
San Diego, CA, USA - January 12, 2026 - Fluxion Therapeutics, a Physiomics Trademark company, today announced the appointment of Vince Groppi, Ph.D., to its Scientific Advisory Board.
Image: https://www.globalnewslines.com/uploads/2026/01/de3b06a2ea4c13e09455e29926ba7f64.jpg
Dr. Vince Groppi brings over three decades of leadership in neuroscience drug discovery, specialized assay development, and translational biomarkers to Fluxion.
Dr. Groppi's career is defined by foundational contributions to ion channel screening. He was a co-inventor of the FLIPR platform, the industry…
What is selenium yeast, and what are its benefits?
Image: https://www.globalnewslines.com/uploads/2026/01/1768205224.jpg
Selenium yeast provides benefits to the body that make it an important health care aid. This natural product is an ingredient that is usually combined with others to form part of supplements for the improvement of the organism, health, and beauty care.
The following content provides information about selenium yeast and its potential benefits.
What is selenium yeast, and its benefits?
Selenium yeast is a type of yeast, usually Saccharomyces cerevisiae, which…
Goodwin Made Releases New Original Single Titled "Pick Yourself Up"
Image: https://www.globalnewslines.com/uploads/2026/01/1768205155.jpg
Deeply personal and inspirational song was written and produced by Ken Goodwin and features powerful lead vocals by Jaime Arin
LOS ANGELES - January 12, 2026 - Goodwin Made today announced the release of a new original single titled "Pick Yourself Up [https://distrokid.com/hyperfollow/goodwinmade/pick-yourself-up-feat-jaime-arin]." Written and produced by Ken Goodwin, the deeply personal and inspirational song features lead vocals by Jaime Arin. "Pick Yourself Up" is a track that speaks directly…
